Covid-19 in liver transplant patients

Authors

  • Marcia Samada Suárez
  • Kenia Valenzuela Aguilera
  • Sheila Moret Vara

Keywords:

Covid-19, trasplante hepático, comorbilidades

Abstract

Introduction. Patients with liver transplant, due to the use of immunosuppressants and the comorbidities they present, may have a higher risk of presenting Covid-19, but its incidence and evolution are still topics of debate.

Objective. To determine the behavior of Covid-19 in liver transplant patients.

Methods. An observational, prospective and longitudinal study was carried out in 17 liver transplant patients from the Surgical Medical Research Center, who acquired Covid-19 between March 2020 and February 2022. Patients who tested positive for SARS-CoV-2 (through the nucleic acid test) were considered COVID-19 positive. The main variables of the study were: age, sex, clinical picture, comorbidities and mortality.

Results. Of 69 patients with liver transplant, 17 (24.6%) had Covid-19, 9 (52.9%) were female and 58.8% were under 60 years of age. Regarding the clinical picture, 9 (52.9%) patients presented the uncomplicated form of the disease, of the comorbidities 94.1% had arterial hypertension, 23 % diabetes mellitus and 17 % renal dysfunction. Mortality from Covid-19 was 11.7 %, the two patients who died had arterial hypertension, previous renal dysfunction, and were older than 60 years.

Conclusions. The behavior of Covid-19 in liver transplant patients could be similar to the general population, with great influence of age and comorbidities on mortality.

Downloads

Published

2022-12-31

How to Cite

1.
Samada Suárez M, Valenzuela Aguilera K, Moret Vara S. Covid-19 in liver transplant patients. Invest Medicoquir [Internet]. 2022 Dec. 31 [cited 2025 Dec. 19];15(1):e796. Available from: https://revcimeq.sld.cu/index.php/imq/article/view/796

Issue

Vol. 15 No. 1 (2023): January-June

Section

Research article

License

The authors retain copyright and all unrestricted publication rights.

Medicoquirúrgicas Research is licensed under the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0) and follows the SciELO Publishing Schema (SciELO PS) for publishing in XML format.

You are free to:

  • Share — copy and redistribute the material in any medium or format.
  • Adapt — remix, transform, and build upon the material.

The license cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do this in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Non-Commercial — You may not use the material for commercial purposes.
No Additional Restrictions — You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where their use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all the permissions you need for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.